Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Leukapheresis × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Ganglioneuroblastoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

pembrolizumab 60 Carboplatin 57 Pemetrexed 47 Cisplatin 36 Paclitaxel 28 Specimen Handling 26 Nivolumab 24 durvalumab 22 osimertinib 21 Magnetic Resonance Spectroscopy 20 Docetaxel 20 Gemcitabine 13 atezolizumab 12 amivantamab 12 Radiotherapy 11 Ipilimumab 11 cemiplimab 10 Cetuximab 10 Drug Therapy 9 130-nm albumin-bound paclitaxel 9 Radiosurgery 8 lazertinib 7 Taxes 7 Bevacizumab 7 Radiation 6 Observation 6 sotorasib 5 alectinib 5 adagrasib 5 Ramucirumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡